Standard-dose gentamicin does not increase risk of patent ductus arteriosus
Background: Rates of patent ductus arteriosus (PDA) and infection are high in preterm infants. Preterm infants with infection are more likely to develop symptomatic PDA, a potentially fatal disease. Clinically, gentamicin is widely used for early-onset infection in neonates including preterm infants...
Saved in:
Main Authors: | Ayana Kishibuchi (Author), Toru Akaike (Author), Susumu Minamisawa (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gentamicin in neonates with hemodynamically significant patent ductus arteriosus
by: Kannan Sridharan, et al.
Published: (2023) -
Late Administration of Surfactant May Increase the Risk of Patent Ductus Arteriosus
by: Fuat Emre Canpolat, et al.
Published: (2020) -
Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases
by: Andrii V Maksymenko, et al.
Published: (2019) -
Ibuprofen and paracetamol for patent ductus arteriosus
by: Carlo Dani
Published: (2014) -
Patent Ductus Arteriosus in Preterm Infants
by: Jia-Yuh Chen
Published: (2012)